Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 5A1 belongs to the large family of olfactory receptors, a subset of G-protein-coupled receptors (GPCRs) characterized by seven transmembrane domains[1][2]. It is responsible for recognizing specific odorant molecules in the nose and initiating a G protein-mediated transduction cascade, leading to a neuronal signal that underlies the sense of smell[1][10]. The olfactory receptor gene family is the largest in the human genome[1][2]. A notable functional aspect of OR5A1 is variation in odor perception; for example, a genetic polymorphism in this receptor leads to differences in sensitivity to beta-ionone, affecting individual perception of floral versus sour/vinegar scents[1]. OR5A1 is a classic olfactory GPCR rather than a therapeutic target, with its primary biological role in chemosensory signaling rather than disease modulation or drug interaction.
Odorant molecules bind to OR5A1, activating G protein-mediated signaling pathways that trigger neuronal responses and olfactory perception[1][2][10]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 5A1 (OR5A1).